BRIEF-EMA Says CHMP Approves 2 Additional Manufacturing Sites For Biontech/Pfizer's COVID-19 Vaccine

Reuters2021-06-22

June 22 (Reuters) - European Medicines Agency:

* EMA : TWO ADDITIONAL MANUFACTURING SITES FOR BIONTECH/PFIZER’S COVID-19 VACCINE :22/06/2021

* EMA - ONE SITE, LOCATED IN REINBEK, GERMANY, OPERATED BY ALLERGOPHARMA GMBH & CO. KG. THE OTHER IN STEIN, SWITZERLAND, IS OPERATED BY NOVARTIS PHARMA

* EMA SAYS ONE SITE, LOCATED IN REINBEK, GERMANY, IS OPERATED BY ALLERGOPHARMA GMBH & CO. KG.

* EMA SAYS THE TWO NEW SITES ARE EXPECTED TO SUPPORT THE CONTINUED SUPPLY OF COMIRNATY IN THE EUROPEAN UNION.

* EMA SAYS THIS RECOMMENDATION DOES NOT REQUIRE A EUROPEAN COMMISSION DECISION AND THE SITES CAN BECOME OPERATIONAL IMMEDIATELY

Further company coverage:

((Reuters.Briefs@thomsonreuters.com ;;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
1